{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:10:45Z","timestamp":1783987845581,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370168"],"award-info":[{"award-number":["82370168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52987-6","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:27:26Z","timestamp":1778682446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EXOSC4 as a novel regulator of neddylation in acute myeloid leukemia"],"prefix":"10.1038","volume":"16","author":[{"given":"Hai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AoShuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiShi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"3","key":"52987_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.stem.2025.01.010","volume":"32","author":"J Hong","year":"2025","unstructured":"Hong, J. et al. PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1. Cell. Stem Cell. 32 (3), 463\u2013478e6. https:\/\/doi.org\/10.1016\/j.stem.2025.01.010 (2025).","journal-title":"Cell. Stem Cell."},{"issue":"1","key":"52987_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian, H. M. et al. Acute myeloid leukemia management and research in 2025. CA Cancer J. Clin. 75 (1), 46\u201367. https:\/\/doi.org\/10.3322\/caac.21873 (2025).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"52987_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41375-024-02471-9","volume":"39","author":"M Hegde","year":"2025","unstructured":"Hegde, M. et al. The co-receptor Neuropilin-1 enhances proliferation in inv(16) acute myeloid leukemia via VEGF signaling. Leukemia 39 (2), 360\u2013370. https:\/\/doi.org\/10.1038\/s41375-024-02471-9 (2025).","journal-title":"Leukemia"},{"issue":"21","key":"52987_CR4","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/s41388-025-03340-0","volume":"44","author":"Y Xie","year":"2025","unstructured":"Xie, Y. et al. Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import. Oncogene 44 (21), 1646\u20131661. https:\/\/doi.org\/10.1038\/s41388-025-03340-0 (2025).","journal-title":"Oncogene"},{"issue":"14","key":"52987_CR5","doi-asserted-by":"publisher","first-page":"e2426742122","DOI":"10.1073\/pnas.2426742122","volume":"122","author":"K Bertulfo","year":"2025","unstructured":"Bertulfo, K. et al. Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. U S A. 122 (14), e2426742122. https:\/\/doi.org\/10.1073\/pnas.2426742122 (2025).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"52987_CR6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1158\/2326-6066.CIR-24-0127","volume":"13","author":"B Jim\u00e9nez-Lasheras","year":"2025","unstructured":"Jim\u00e9nez-Lasheras, B. et al. NEDDylation regulates CD8\u2009+\u2009T-cell metabolism and antitumor immunity. Cancer Immunol. Res. 13 (7), 1004\u20131021. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-0127 (2025).","journal-title":"Cancer Immunol. Res."},{"issue":"33","key":"52987_CR7","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/s41388-025-03468-z","volume":"44","author":"F Liu","year":"2025","unstructured":"Liu, F. et al. PTEN neddylation aggravates CDK4\/6 inhibitor resistance in breast cancer. Oncogene 44 (33), 2997\u20133013. https:\/\/doi.org\/10.1038\/s41388-025-03468-z (2025).","journal-title":"Oncogene"},{"key":"52987_CR8","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.redox.2025.103655","volume":"83","author":"S Issa","year":"2025","unstructured":"Issa, S. et al. Redox-driven regulation of UCHL3\/Yuh1 influences mitochondrial health via the NEDD8\/Rub1 pathway. Redox Biol. 83, 103655. https:\/\/doi.org\/10.1016\/j.redox.2025.103655 (2025).","journal-title":"Redox Biol."},{"issue":"8","key":"52987_CR9","doi-asserted-by":"publisher","first-page":"BSR20220994","DOI":"10.1042\/BSR20220994","volume":"42","author":"Y Chen","year":"2022","unstructured":"Chen, Y. & Sun, L. Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway. Biosci. Rep. 42 (8), BSR20220994. https:\/\/doi.org\/10.1042\/BSR20220994 (2022).","journal-title":"Biosci. Rep."},{"issue":"1","key":"52987_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Yu, Q., Li, Z., Zhao, Y. & Sun, Y. Protein neddylation and its role in health and diseases. Signal. Transduct. Target. Ther. 9 (1), 85. https:\/\/doi.org\/10.1038\/s41392-024-01800-9 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"52987_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40364-023-00545-x","volume":"12","author":"D Liu","year":"2024","unstructured":"Liu, D., Che, X. & Wu, G. Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. Biomark. Res. 12, 5. https:\/\/doi.org\/10.1186\/s40364-023-00545-x (2024).","journal-title":"Biomark. Res."},{"issue":"1","key":"52987_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13045-023-01476-8","volume":"16","author":"NJ Short","year":"2023","unstructured":"Short, N. J. et al. A phase 1\/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents. J. Hematol. Oncol. 16 (1), 73. https:\/\/doi.org\/10.1186\/s13045-023-01476-8 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"52987_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-024-02203-8","volume":"24","author":"C Can","year":"2025","unstructured":"Can, C. et al. Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity. Mol. Cancer. 24 (1), 4. https:\/\/doi.org\/10.1186\/s12943-024-02203-8 (2025).","journal-title":"Mol. Cancer"},{"key":"52987_CR14","doi-asserted-by":"publisher","first-page":"111583","DOI":"10.1016\/j.cellsig.2024.111583","volume":"127","author":"R Bian","year":"2025","unstructured":"Bian, R. et al. HDAC inhibitor enhances ferroptosis susceptibility of AML cells by stimulating iron metabolism. Cell. Signal. 127, 111583. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111583 (2025).","journal-title":"Cell. Signal."},{"key":"52987_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2025.2497041","author":"J Jian","year":"2025","unstructured":"Jian, J., Guo, Y., Tang, X., Zhao, L. & Liu, B. Integrated transcriptome profiling and in vitro analysis reveals MLN4924\u2019s role in inducing ferroptosis in acute myeloid leukemia. Hematology. https:\/\/doi.org\/10.1080\/16078454.2025.2497041. (2025). (Published online December 31)","journal-title":"Hematology"},{"issue":"1","key":"52987_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12967-025-06667-0","volume":"23","author":"C Yao","year":"2025","unstructured":"Yao, C. et al. Identification EXOSC4 as a novel autoantigen of interstitial lung disease in rheumatoid arthritis. J. Transl Med. 23 (1), 765. https:\/\/doi.org\/10.1186\/s12967-025-06667-0 (2025).","journal-title":"J. Transl Med."},{"key":"52987_CR17","doi-asserted-by":"publisher","first-page":"118597","DOI":"10.1016\/j.lfs.2020.118597","volume":"263","author":"YX Wang","year":"2020","unstructured":"Wang, Y. X. et al. STX2 drives colorectal cancer proliferation via upregulation of EXOSC4. Life Sci. 263, 118597. https:\/\/doi.org\/10.1016\/j.lfs.2020.118597 (2020).","journal-title":"Life Sci."},{"issue":"3","key":"52987_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10142-024-01363-6","volume":"24","author":"N Wang","year":"2024","unstructured":"Wang, N. et al. RUNX3 exerts tumor-suppressive role through inhibiting EXOSC4 expression. Funct. Integr. Genomics. 24 (3), 103. https:\/\/doi.org\/10.1007\/s10142-024-01363-6 (2024).","journal-title":"Funct. Integr. Genomics"},{"issue":"1","key":"52987_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jleuko\/qiae041","volume":"116","author":"L Qin","year":"2024","unstructured":"Qin, L. et al. Construction of an immune-related prognostic signature and lncRNA-miRNA-mRNA ceRNA network in acute myeloid leukemia. J. Leukoc. Biol. 116 (1), 146\u2013165. https:\/\/doi.org\/10.1093\/jleuko\/qiae041 (2024).","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"52987_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-024-02013-y","volume":"23","author":"D Wen","year":"2024","unstructured":"Wen, D., Xiao, H., Gao, Y., Zeng, H. & Deng, J. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2. Mol. Cancer. 23 (1), 116. https:\/\/doi.org\/10.1186\/s12943-024-02013-y (2024).","journal-title":"Mol. Cancer"},{"issue":"1","key":"52987_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-024-02198-2","volume":"24","author":"MA Freitas-Cortez","year":"2025","unstructured":"Freitas-Cortez, M. A. et al. Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Mol. Cancer. 24 (1), 40. https:\/\/doi.org\/10.1186\/s12943-024-02198-2 (2025).","journal-title":"Mol. Cancer"},{"key":"52987_CR22","doi-asserted-by":"publisher","first-page":"177652","DOI":"10.1016\/j.ejphar.2025.177652","volume":"998","author":"M Zhong","year":"2025","unstructured":"Zhong, M. et al. Synergistic effects of BET inhibitors and ferroptosis inducers via targeted inhibition of the BRD4\/c-Myc\/NRF2 pathway in AML. Eur. J. Pharmacol. 998, 177652. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177652 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"52987_CR23","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.redox.2020.101619","volume":"36","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 36, 101619. https:\/\/doi.org\/10.1016\/j.redox.2020.101619 (2020).","journal-title":"Redox Biol."},{"issue":"9","key":"52987_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41419-021-04128-2","volume":"12","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. CISD3 inhibition drives cystine-deprivation induced ferroptosis. Cell. Death Dis. 12 (9), 839. https:\/\/doi.org\/10.1038\/s41419-021-04128-2 (2021).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"52987_CR25","doi-asserted-by":"publisher","first-page":"20230845","DOI":"10.1515\/med-2023-0845","volume":"19","author":"Q Zou","year":"2024","unstructured":"Zou, Q., Tang, B., Chen, X., Zhang, C. & Huang, Y. STK11 (LKB1) mutation suppresses ferroptosis in lung adenocarcinoma by facilitating monounsaturated fatty acid synthesis. Open. Med. (Wars). 19 (1), 20230845. https:\/\/doi.org\/10.1515\/med-2023-0845 (2024).","journal-title":"Open. Med. (Wars)"},{"key":"52987_CR26","doi-asserted-by":"publisher","first-page":"1131201","DOI":"10.3389\/fphys.2023.1131201","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. The roles of sirtuins in ferroptosis. Front. Physiol. 14, 1131201. https:\/\/doi.org\/10.3389\/fphys.2023.1131201 (2023).","journal-title":"Front. Physiol."},{"key":"52987_CR27","doi-asserted-by":"publisher","first-page":"901565","DOI":"10.3389\/fmolb.2022.901565","volume":"9","author":"C Cui","year":"2022","unstructured":"Cui, C., Yang, F. & Li, Q. Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases. Front. Mol. Biosci. 9, 901565. https:\/\/doi.org\/10.3389\/fmolb.2022.901565 (2022).","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"52987_CR28","doi-asserted-by":"publisher","first-page":"103054","DOI":"10.1016\/j.jbc.2023.103054","volume":"299","author":"H Deng","year":"2023","unstructured":"Deng, H. et al. SET7 methylates the deubiquitinase OTUB1 at Lys 122 to impair its binding to E2 enzyme UBC13 and relieve its suppressive role on ferroptosis. J. Biol. Chem. 299 (4), 103054. https:\/\/doi.org\/10.1016\/j.jbc.2023.103054 (2023).","journal-title":"J. Biol. Chem."},{"key":"52987_CR29","doi-asserted-by":"publisher","first-page":"1383203","DOI":"10.3389\/fphar.2024.1383203","volume":"15","author":"MAU Din","year":"2024","unstructured":"Din, M. A. U., Lin, Y., Wang, N., Wang, B. & Mao, F. Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer. Front. Pharmacol. 15, 1383203. https:\/\/doi.org\/10.3389\/fphar.2024.1383203 (2024).","journal-title":"Front. Pharmacol."},{"issue":"28","key":"52987_CR30","doi-asserted-by":"publisher","first-page":"e2320655121","DOI":"10.1073\/pnas.2320655121","volume":"121","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. The CRL3KCTD10 ubiquitin ligase-USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11. Proc. Natl. Acad. Sci. U S A. 121 (28), e2320655121. https:\/\/doi.org\/10.1073\/pnas.2320655121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"52987_CR31","doi-asserted-by":"publisher","first-page":"2497041","DOI":"10.1080\/16078454.2025.2497041","volume":"30","author":"J Jian","year":"2025","unstructured":"Jian, J., Guo, Y., Tang, X., Zhao, L. & Liu, B. Integrated transcriptome profiling and in vitro analysis reveals MLN4924\u2019s role in inducing ferroptosis in acute myeloid leukemia. Hematology 30 (1), 2497041. https:\/\/doi.org\/10.1080\/16078454.2025.2497041 (2025).","journal-title":"Hematology"},{"issue":"1","key":"52987_CR32","doi-asserted-by":"publisher","first-page":"30361","DOI":"10.1038\/s41598-025-15758-3","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Zhao, M., Chu, T., Wei, J. & Jia, Q. Comprehensive bioinformatics analysis of EXOSC family genes in head and neck squamous cell carcinoma. Sci. Rep. 15 (1), 30361. https:\/\/doi.org\/10.1038\/s41598-025-15758-3 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"52987_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/ijms23010496","volume":"23","author":"K Taniue","year":"2022","unstructured":"Taniue, K. et al. RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival. Int. J. Mol. Sci. 23 (1), 496. https:\/\/doi.org\/10.3390\/ijms23010496 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"52987_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41589-024-01683-5","volume":"21","author":"Z Peng","year":"2025","unstructured":"Peng, Z. et al. Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. Nat. Chem. Biol. 21 (1), 59\u201370. https:\/\/doi.org\/10.1038\/s41589-024-01683-5 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"52987_CR35","doi-asserted-by":"publisher","unstructured":"(PDF). Cytoplasmic NEAT1 Suppresses AML Stem Cell Self-Renewal and Leukemogenesis through Inactivation of Wnt Signaling. ResearchGate. https:\/\/doi.org\/10.1002\/advs.202100914","DOI":"10.1002\/advs.202100914"},{"key":"52987_CR36","doi-asserted-by":"publisher","first-page":"797968","DOI":"10.3389\/fonc.2021.797968","volume":"11","author":"C Xiong","year":"2021","unstructured":"Xiong, C., Sun, Z., Yu, J. & Lin, Y. Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion via the Wnt Pathway. Front. Oncol. 11, 797968. https:\/\/doi.org\/10.3389\/fonc.2021.797968 (2021).","journal-title":"Front. Oncol."},{"issue":"1","key":"52987_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"52987_CR38","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"52987_CR39","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52987-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:44Z","timestamp":1783987244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52987"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52987-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the Institutional Ethics Committee of Basic Medical Research, Affiliated Hospital of Guizhou Medical University (Approval No. 2023-253). Written informed consent was obtained from all adult participants for the research use and publication of de-identified data. For the use of residual, de-identified by-products of routine care, the requirement for informed consent was waived by the ethics committee in accordance with national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants who provided bone marrow samples for this study signed written informed consent, agreeing to the use of their de-identified data\/images for research and publication. For the use of residual, de-identified clinical samples obtained after routine diagnosis or treatment, their utilization was conducted in accordance with national regulations, following the acquisition of participant informed consent or a waiver of informed consent. This consent procedure and the complete study protocol were reviewed and approved by the Institutional Ethics Committee of Basic Medical Research, Affiliated Hospital of Guizhou Medical University (Approval No. 2023-253).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21954"}}